The Limonoids TS3 and Rubescin E Induce Apoptosis in Human Hepatoma Cell Lines and Interfere with NF-κB Signaling

Hepatocellular carcinoma (HCC) is extremely resistant towards pharmacological therapy. To date, the multi-kinase inhibitor Sorafenib is the only available therapeutic agent with the potential to prolong patient survival. Using the human hepatoma cell lines HepG2 and Huh7, we analyzed anti-cancer act...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Nicole, Tontsa, Armelle Tsamo, Wegscheid, Claudia, Mkounga, Pierre, Nkengfack, Augustin Ephrem, Loscher, Christine, Sass, Gabriele, Tiegs, Gisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982607/
https://www.ncbi.nlm.nih.gov/pubmed/27518192
http://dx.doi.org/10.1371/journal.pone.0160843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982607/
https://www.ncbi.nlm.nih.gov/pubmed/27518192
http://dx.doi.org/10.1371/journal.pone.0160843

Ejemplares similares